Atjaunināt sīkdatņu piekrišanu

Treating Addiction to Tobacco and Nicotine Products [Mīkstie vāki]

  • Formāts: Paperback / softback, 284 pages, height x width x depth: 229x152x17 mm, 29 Tables, unspecified; 3 Illustrations, black and white; 15 Line drawings, black and white
  • Izdošanas datums: 01-Feb-2025
  • Izdevniecība: American Psychiatric Association Publishing
  • ISBN-10: 161537468X
  • ISBN-13: 9781615374687
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 71,62 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Paperback / softback, 284 pages, height x width x depth: 229x152x17 mm, 29 Tables, unspecified; 3 Illustrations, black and white; 15 Line drawings, black and white
  • Izdošanas datums: 01-Feb-2025
  • Izdevniecība: American Psychiatric Association Publishing
  • ISBN-10: 161537468X
  • ISBN-13: 9781615374687
Citas grāmatas par šo tēmu:

Synthesizing the latest research and literature, Treating Addiction to Tobacco and Nicotine Products provides a comprehensive analysis of assessing and treating tobacco use disorder.Smoking rates have declined for decades, yet smoking remains the leading cause of preventable death in the United States, responsible for more 400,000 premature deaths annually in this country and more than 4.9 million deaths worldwide.

Featuring numerous case vignettes that bring the topics to life, this volume covers:

• Trends in cigarette smoking and its associated harms• Patterns of use, addictiveness, and health effects of non-cigarette tobacco products, including e-cigarettes, cigars, and pipes• Assessing tobacco use disorder• Behavioral and pharmacological interventions for tobacco use disorder• The need for systems change in health care settings

Special emphasis is placed on individuals with mental illness, who are disproportionately represented among users of tobacco products. The book explores tobacco use in this population and explains the impact of this comorbidity on treatment and cessation.

With summary key points at the end of each chapter to distill clinical highlights, Treating Addiction to Tobacco and Nicotine Products is an essential resource for busy clinicians across various health care disciplines.



"Since the invention of the cigarette-making machine towards the end of the nineteenth century and then throughout the twentieth century, cigarettes have been by far the most common form of nicotine consumption in the United States, with cigars and oral tobacco (chew and snuff) trailing far behind. Despite declines in smoking, it remains the number one cause of preventable death in the United States. It has been estimated that tobacco smoking causes over 400,000 premature deaths per year in the United States and 4.9 million deaths per year worldwide (8.8% of all global deaths). Since only the beginning of the twenty-first century has the tobacco industry acknowledged the scientific consensus on the addictiveness and other health effects of cigarettes andhas diversified into marketing a range of other products. The 1964 U.S. Surgeon General's report on tobacco and health concluded that cigarettes are a cause of lung cancer, and numerous follow-up reports clarified the enormous harmfulness of cigarette smoking. This book describes the harms to health from smoking cigarettes and other tobacco products, the relative harms from non-smoked nicotine products, the neurobiology of tobacco/nicotine dependence and addiction, comorbidities of tobacco addiction withother behavioral health conditions, and ways to address tobacco/nicotine use in the clinical setting and engage patients in treatment"--

Chapter
1. Trends in and Harms From Cigarette SmokingChapter
2. Non-Cigarette Tobacco Products:Health Risks, Addictiveness, and Patterns of UseChapter
3. Tobacco Use Disorder, Dependence, and AddictionChapter
4. Assessment of Tobacco Use and Tobacco Use DisorderChapter
5. Tobacco Comorbidity With Other Behavioral Health ConditionsChapter
6. Behavioral Interventions for Individuals Who Are Ready to Quit SmokingChapter
7. Pharmacological and Other Biological Treatments for Tobacco Use DisorderChapter
8. Engaging Individuals Into TreatmentChapter
9. Preventing a Return to Smoking and Creating a Tobacco-Free LifestyleChapter
10. Approach to Tobacco in the Clinical SettingChapter
11. Addressing Mental Illness and Other Substance Use During Treatment for Tobacco Use DisorderChapter
12. Switching From Smoked to Non-Smoked Nicotine ProductsIndex

Jill M. Williams, M.D., is a Professor of Psychiatry and Director of the Division of Addiction Psychiatry at the Rutgers UniversityRobert Wood Johnson Medical School in New Brunswick, New Jersey.





Jonathan Foulds, Ph.D., is a Professor of Public Health Sciences and Psychiatry and Co-director of the Penn State Center for Research on Tobacco and Health at Penn State University College of Medicine in Hershey, Pennsylvania.